One in eight Britons could be using weight-loss medication by next year, according to a new report which predicts the number of adults taking GLP-1 drugs will more than double to seven million. Analysis by consulting firm PwC Strategy& forecasts that the number of UK adults using glucagon-like peptide-1 (GLP-1) medications will rise from around three million today to seven million by 2027, equivalent to approximately 13 per cent of the populatio…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.